Production (Stage)
Oscar Health, Inc.
OSCR
$14.17
-$0.20-1.39%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.04B | 2.39B | 2.42B | 2.21B | 2.14B |
| Total Other Revenue | 4.33M | 4.81M | 4.90M | 5.23M | 5.63M |
| Total Revenue | 3.05B | 2.39B | 2.42B | 2.22B | 2.14B |
| Cost of Revenue | 2.26B | 2.07B | 2.00B | 1.71B | 1.55B |
| Gross Profit | 786.61M | 327.32M | 419.50M | 510.62M | 587.53M |
| SG&A Expenses | 482.76M | 465.82M | 460.38M | 435.21M | 394.16M |
| Depreciation & Amortization | 6.73M | 9.23M | 7.50M | 7.60M | 7.81M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.75B | 2.54B | 2.47B | 2.15B | 1.96B |
| Operating Income | 297.12M | -147.73M | -48.37M | 67.81M | 185.56M |
| Income Before Tax | 288.21M | -153.69M | -52.31M | 60.95M | 178.48M |
| Income Tax Expenses | 12.71M | -404.00K | 2.08M | 4.64M | 996.00K |
| Earnings from Continuing Operations | 275.51M | -153.29M | -54.39M | 56.31M | 177.48M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -235.00K | -262.00K | -208.00K | -105.00K | -114.00K |
| Net Income | 275.27M | -153.55M | -54.60M | 56.21M | 177.37M |
| EBIT | 297.12M | -147.73M | -48.37M | 67.81M | 185.56M |
| EBITDA | 303.85M | -138.50M | -40.87M | 75.41M | 193.37M |
| EPS Basic | 1.10 | -0.62 | -0.22 | 0.24 | 0.77 |
| Normalized Basic EPS | 0.72 | -0.39 | -0.14 | 0.16 | 0.48 |
| EPS Diluted | 0.92 | -0.68 | -0.22 | 0.20 | 0.62 |
| Normalized Diluted EPS | 0.59 | -0.39 | -0.14 | 0.13 | 0.38 |
| Average Basic Shares Outstanding | 251.28M | 248.21M | 243.11M | 238.67M | 231.44M |
| Average Diluted Shares Outstanding | 305.94M | 248.21M | 243.11M | 303.97M | 293.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |